Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by Strathroy50on Oct 24, 2007 2:41pm
515 Views
Post# 13681363

House Positions

House PositionsVolume nothing to write home about with BMO buying almost a 1/3 of the shares today. Nice to see us green but would be more interested if we were trading 3 - 400,000 shares. Now that would put us in teen territory (or higher) in a hurry. House Positions Exch House Bought $Value Ave Sold $Value Ave Net $Net T 9 BMO Nesbitt 17,990 186,538 10.37 3,080 32,090 10.42 14,910 -154,448 T 77 Peters 5,000 52,469 10.49 0 5,000 -52,469 T 27 Dundee 3,800 39,276 10.34 0 3,800 -39,276 T 145 Woodstone 3,100 32,548 10.50 0 3,100 -32,548 T 7 TD Sec 11,100 115,119 10.37 9,300 96,720 10.40 1,800 -18,399 T 85 Scotia 2,850 29,496 10.35 1,500 15,520 10.35 1,350 -13,976 T 80 National Bank 1,000 10,364 10.36 0 1,000 -10,364 T 62 Haywood 1,000 10,440 10.44 0 1,000 -10,440 T 81 HSBC 900 9,450 10.50 0 900 -9,450 T 79 CIBC 9,950 103,694 10.42 9,200 96,221 10.46 750 -7,473 T 88 E-TRADE 1,300 13,522 10.40 700 7,255 10.36 600 -6,267 T 48 Laurentian 400 4,120 10.30 0 400 -4,120 T 124 Questrade 0 200 2,080 10.40 -200 2,080 T 89 Raymond James 430 4,493 10.45 790 8,191 10.37 -360 3,698 T 75 MGI 0 400 4,172 10.43 -400 4,172 T 46 Blackmont 0 2,000 21,000 10.50 -2,000 21,000 T 2 RBC 100 1,050 10.50 4,150 42,765 10.30 -4,050 41,715 T 33 Canaccord 2,500 25,975 10.39 8,700 89,783 10.32 -6,200 63,808 T 39 Merrill Lynch 1,200 12,358 10.30 9,500 98,363 10.35 -8,300 86,005 T 1 Anonymous 3,800 39,502 10.40 16,900 176,254 10.43 -13,100 136,752 Total 66,420 690,414 10.39 66,420 690,414 10.39 0 0
Bullboard Posts